181 related articles for article (PubMed ID: 37711064)
21. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
[TBL] [Abstract][Full Text] [Related]
22. Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy.
Lee HJ; Kim HK; Lee SC; Kim J; Park JB; Hwang IC; Choi YJ; Lee SP; Chang SA; Lee W; Park EA; Cho GY; Kim YJ
Eur Heart J Cardiovasc Imaging; 2022 Jul; 23(8):1108-1116. PubMed ID: 34542591
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
[TBL] [Abstract][Full Text] [Related]
24. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
[TBL] [Abstract][Full Text] [Related]
26. Thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction.
Li X; Yao Y; Chen Z; Fan S; Hua W; Zhang S; Fan X
Clin Cardiol; 2019 Jan; 42(1):120-128. PubMed ID: 30447088
[TBL] [Abstract][Full Text] [Related]
27. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
[TBL] [Abstract][Full Text] [Related]
29. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
30. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
[TBL] [Abstract][Full Text] [Related]
31. Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy.
Zhang Y; Zhu Y; Wang D; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
Heart Rhythm; 2023 Jul; 20(7):958-967. PubMed ID: 36870381
[TBL] [Abstract][Full Text] [Related]
32. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
33. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
[TBL] [Abstract][Full Text] [Related]
34. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy.
Zegkos T; Tziomalos G; Parcharidou D; Ntelios D; Papanastasiou CA; Karagiannidis E; Gossios T; Rouskas P; Katranas S; Paraskevaidis S; Karvounis H; Efthimiadis G
Hellenic J Cardiol; 2022; 63():15-21. PubMed ID: 34147674
[TBL] [Abstract][Full Text] [Related]
35. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.
Iervasi G; Pingitore A; Landi P; Raciti M; Ripoli A; Scarlattini M; L'Abbate A; Donato L
Circulation; 2003 Feb; 107(5):708-13. PubMed ID: 12578873
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction.
Choi YJ; Lee HJ; Park JS; Park CS; Rhee TM; Choi JY; Choi HM; Park JB; Yoon YE; Lee SP; Na JO; Cho GY; Kim YJ; Hwang IC; Kim HK
Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1374-1383. PubMed ID: 37467475
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
[TBL] [Abstract][Full Text] [Related]
38. Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
Boleti OD; Roussos S; Norrish G; Field E; Oates S; Tollit J; Nepali G; Bhole V; Uzun O; Daubeney PEF; Stuart GA; Fernandes P; McLeod K; Ilina M; Liaqath MNA; Bharucha T; Delle Donne G; Brown E; Linter K; Khodaghalian B; Jones C; Searle J; Mathur S; Boyd N; Reindhardt Z; Duignan S; Prendiville T; Adwani S; Zenker M; Wolf CM; Kaski JP
Int J Cardiol; 2023 Dec; 393():131405. PubMed ID: 37777071
[TBL] [Abstract][Full Text] [Related]
39. A Low-Normal Free Triiodothyronine Level Is Associated with Adverse Prognosis in Euthyroid Patients with Heart Failure Receiving Cardiac Resynchronization Therapy.
Chen YY; Shu XR; Su ZZ; Lin RJ; Zhang HF; Yuan WL; Wang JF; Xie SL
Int Heart J; 2017 Dec; 58(6):908-914. PubMed ID: 29151481
[TBL] [Abstract][Full Text] [Related]
40. Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome.
D'Aloia A; Vizzardi E; Bugatti S; Rovetta R; Bonadei I; Del Magro F; Curnis A; Dei Cas L
J Investig Med; 2012 Aug; 60(6):907-10. PubMed ID: 22722568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
